BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22477643)

  • 1. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.
    Lu W; Zhang C; Yi Z; Li Z; Wu Z; Fang Y
    J Mol Neurosci; 2012 Jul; 47(3):505-10. PubMed ID: 22477643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients.
    Chung S; Chung HY; Jung J; Chang JK; Hong JP
    Compr Psychiatry; 2010; 51(4):367-72. PubMed ID: 20579509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
    Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of Val66Met polymorphism of brain-derived neurotrophic factor gene with cognitive impairment and clinical symptoms in first episode schizophrenia].
    Zhang C; Gu X; Wang Q; Li M; Deng W; Guo W; Zhao L; Ma X; Li T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):592-596. PubMed ID: 28777866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction effect between BDNF val66met polymorphism and obesity on executive functions and frontal structure.
    Marqués-Iturria I; Garolera M; Pueyo R; Segura B; Hernan I; García-García I; Sánchez-Garre C; Vernet-Vernet M; Sender-Palacios MJ; Narberhaus A; Ariza M; Junqué C; Jurado MÁ
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):245-53. PubMed ID: 24619555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
    Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia.
    Ho BC; Andreasen NC; Dawson JD; Wassink TH
    Am J Psychiatry; 2007 Dec; 164(12):1890-9. PubMed ID: 18056245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF Val66Met polymorphism and anxiety/depression symptoms in schizophrenia in a Chinese Han population.
    Sun MM; Yang LM; Wang Y; Feng X; Cui KY; Liu LF; Chen ZY
    Psychiatr Genet; 2013 Jun; 23(3):124-9. PubMed ID: 23532065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BDNF Gene Val66Met Polymorphism with Suicide Attempts, Focused Attention and Response Inhibition in Patients with Schizophrenia.
    Bolat Kaya Ö; Kaya H; Civan Kahve A; Enez Darçin A; Yalçin Çavuş RS; Dilbaz N
    Noro Psikiyatr Ars; 2022; 59(2):91-97. PubMed ID: 35685050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
    Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
    Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
    Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
    Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
    Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
    Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.
    Xu MQ; St Clair D; Ott J; Feng GY; He L
    Schizophr Res; 2007 Mar; 91(1-3):6-13. PubMed ID: 17289348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.